TROPION-Lung04: Phase 1b, multicenter study of datopotamab deruxtecan (Dato-DXd) in combination with immunotherapy ± carboplatin in advanced/metastatic non-small cell lung cancer (mNSCLC).
暂无分享,去创建一个
H. Borghaei | K. Papadopoulos | A. Spira | S. Kitazono | S. Waqar | J. Olivares | Susan C Lovick | K. Wakuda | G. Mak | D. Bruno | L. Goodwin